Chronic Neuropathic Pain
21
9
10
4
Key Insights
Highlights
Success Rate
44% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 80/100
23.8%
5 terminated out of 21 trials
44.4%
-42.1% vs benchmark
29%
6 trials in Phase 3/4
25%
1 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 4 completed trials
Clinical Trials (21)
Ecstasy to Alleviate SEvere Chronic Neuropathic Pain Trial
Mechanisms of Stimulation for Pain Alleviation
aiTBS and rTMS in Neuropathic Pain and Prediction of Response
Safety and Tolerability Study of ST-503 for Refractory Pain Due to Peripheral Neuropathy (Small Fiber Predominant, SFN)
Exploring Neurosphere's Remote Monitoring and Virtual Clinic Features in Improve Quality of Life and Reduce Costs
Low Dose Naltrexone for Pain in Patients With HIV
High-Frequency rTMS Over the DLPFC for Chronic Low Back Pain
Transcranial Magnetic Stimulation for Chronic Neuropathic Pain
Evaluation of the Efficacy of STNS With FAST and MULTIWAVE in Patients With Refractory Chronic Neuropathic Pain
VIRTUAL WALKING AND TRANSCRANIAL DIRECT CURRENT STIMULATION FOR CHRONIC NEUROPATHIC PAIN DUE TO SPINAL CORD INJURY
Efficacy of Repetitive Transcranial Magnetic Stimulation Over the Primary Cortex in Patients With Neuropathic Pain and Cancer
Psilocybin for Enhanced Analgesia in Chronic nEuropathic PAIN
Study of RTMS Analgesic Effect in Chronic Neuropathic Pain,
Surgical Treatment of Chronic Neuropathic Pain
Methadone in Neuropathic Pain
A Post Market Cohort to Assess the Performance of the Spinal Modulation Neurostimulator System for the Management of Chronic Neuropathic Pain of the Foot and/or Lower Leg
Effectiveness of Repetitive Transcranial Magnetic Stimulation in the Treatment of Chronic Neuropathic Pain
Study to Evaluate the Efficacy and Safety of ORAVESCENT Fentanyl Citrate for the Management of Breakthrough Pain
Molecular Mediators of Nerve Injury Signaling
Effects of Amitriptyline for the Treatment of Pain on Driving Performance and Cognition.